FOLLOWUS
1.Institute of Traditional Chinese Medicine Related Comorbid Depression, Nanjing University of Chinese Medicine, Nanjing(210029), China
2.Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou(310053), China
Prof. HUANG Xi, E-mail: 290606@njucm.edu.cn
纸质出版日期:2024-05,
网络出版日期:2024-02-02,
录用日期:2023-08-02
Scan for full text
可吸收生物活性成分复制了GXⅡ诱导的内皮相关的体内/体外血管舒张作用[J]. 中国结合医学杂志(英文版), 2024,30(5):387-397.
XU Min, LIU Hao, SU Meng-qing, et al. Absorbed Bioactive Compounds Replicate Guanxin Ⅱ-Induced Endothelium-Associated
可吸收生物活性成分复制了GXⅡ诱导的内皮相关的体内/体外血管舒张作用[J]. 中国结合医学杂志(英文版), 2024,30(5):387-397. DOI: 10.1007/s11655-024-3651-6.
XU Min, LIU Hao, SU Meng-qing, et al. Absorbed Bioactive Compounds Replicate Guanxin Ⅱ-Induced Endothelium-Associated
目的
2
建立一种快速无干扰的方法
以阐明冠心Ⅱ (GXⅡ) 在众多植物化学中具有代表性舒血管作用的可吸收生物活性成分 (ABCs) .
研究方法
2
采用超高效液相色谱-质谱法检测口服 GXⅡ (30 g/kg) 后大鼠血清和GXII方剂中阿魏酸、丹参酚和羟基红花黄色素 A (FTA) 的含量. 采用随机数字表法将18只大鼠随机分配到对照组 (0.9%生理盐水) 、GXⅡ (30克/千克) 和FTA (5、28和77mg/kg) . 测定了舒张期冠状动脉血流速度-时间积分 (VTI)
即冠状动脉血流或冠状动脉血流介导的扩张 (CFMD) 和离体主动脉环的完整内皮的血管张力. 将内皮细胞 (ECs) 暴露于空白培养基或 0.5 mmol/L H2O2 12 小时后
用口服GXⅡ后的去蛋白血清上清液 (PGSDS
每 1 mL 培养基含 300 μL PGSDS) 或 FTA (237、1539 和 1510 mg/mL)处理细胞 10 分钟作为对照组
H2O2 组、PGSDS 组和 FTA 组. 测定了一氧化氮 (NO) 、血管内皮生长因子 (VEGF)、内皮素-1 (ET-1)、超氧化物歧化酶 (SOD)、丙二醛 (MDA)、磷酸化磷酸肌酸 3 激酶 (p-PI3K)、磷酸化蛋白激酶 B (p-AKT)、磷酸化内皮一氧化氮合酶 (p-AKT)、磷酸化内皮一氧化氮合酶 (p-eNOS) 水平. PGSDS 被设计为体外GXII中草药粗提物的代用指标.
结果
2
PGSDS能有效地消除GXⅡ粗制剂引起的伪性反应. 当剂量等于GXⅡ/其给药后血清中的含量时
FTA占GXⅡ添加CFMD的98.17%
PGSDS降低血管张力的92.99%. 在ECs中
FTA/PGSDS具有显著的抗氧化作用 (降低MDA和升高SOD
P
<
0.01) 和内皮功能保护作用 (降低VEGF和ET-1
P
<
0.01) . ng-硝基-l-精氨酸甲酯 (L-NA
eNOS抑制剂) 和沃特曼素 (PI3K/AKT抑制剂) 分别显著消除了FTA-PGSDS诱导的主动脉舒张、内皮NO水平和磷酸化的PI3K/Akt/eNOS蛋白的升高
表明PI3K/AKT-eNOS通路的内皮依赖性血管舒张 (
P
<
0.01) .
结论
2
本研究为快速、准确地阐明GXⅡ具有代表性的体外心脏保护吸收生物活性化合物 (ABCs) -FTA提供了一种策略
提示其在推进精准民族医学方面的潜力.
Objective:
2
To develop an interference-free and rapid method to elucidate Guanxin Ⅱ (GXⅡ)'s representative vasodilator absorbed bioactive compounds (ABCs) among enormous phytochemicals.
Methods:
2
The contents of ferulic acid
tanshinol
and hydroxysafflor yellow A (FTA) in GXⅡ/rat serum after the oral administration of GXⅡ (30 g/kg) were detected using ultra-performance liquid chromatography-mass spectrometry. Totally 18 rats were randomly assigned to the control group (0.9% normal saline)
GXⅡ (30 g/kg) and FTA (5
28 and 77 mg/kg) by random number table method. Diastolic coronary flow velocity-time integral (VTI)
i.e.
coronary flow or coronary flow-mediated dilation (CFMD)
and endothelium-intact vascular tension of isolated aortic rings were measured. After 12 h of exposure to blank medium or 0.5 mmol/L H
2
O
2
endothelial cells (ECs) were treated with post-dose GXⅡ of supernatant from deproteinized serum (PGSDS
300 μL PGSDS per 1 mL of culture medium) or FTA (237
1539
and 1510 mg/mL) for 10 min as control
H
2
O
2
PGSDS and FTA groups. Nitric oxide (NO)
vascular endothelial growth factor (VEGF)
endothelin-1 (ET-1)
superoxide dismutase (SOD)
malondialdehyde (MDA) and phosphorylated phosphoinositide 3 kinase (p-PI3K)
phosphorylated protein kinase B (p-AKT)
phosphorylated endothelial nitric oxide synthase (p-eNOS) were analyzed. PGSDS was developed as a GXⅡ proxy of
ex vivo
herbal crude extracts.
Results:
2
PGSDS effectively eliminates false responses caused by crude GXⅡ preparations. When doses equaled the contents in GXⅡ/its post-dose serum
FTA accounted for 98.17% of GXⅡ-added CFMD and 92.99% of PGSDS-reduced vascular tension. In ECs
FTA/PGSDS was found to have significant antioxidant (lower MDA and higher SOD
P
<
0.01) and endothelial function-protective (lower VEGF
ET-1
P
<
0.01) effects. The increases in aortic relaxation
endothelial NO levels and phosphorylated PI3K/Akt/eNOS protein induced by FTA/PGSDS were markedly abolished by NG-nitro-L-arginine methyl ester (L-NA
eNOS inhibitor) and wortmannin (PI3K/AKT inhibitor)
respectively
indicating an endothelium-dependent vasodilation via the PI3K/AKT-eNOS pathway (
P
<
0.01).
Conclusion:
2
This study provides a strategy for rapidly and precisely elucidating GXⅡ's representative
in
/
ex vivo
cardioprotective absorbed bioactive compounds (ABCs)-FTA
suggesting its potential in advancing precision ethnomedicine.
超高效液相色谱-质谱内皮依赖性血管舒张草药提取物冠心二号可吸收生物活性成分
ultra-performance liquid chromatography-mass spectrometryendothelium-dependent vasodilationherbal extractGuanxin Ⅱabsorbed bioactive compound
0
浏览量
0
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构